In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Torrent Pharmaceuticals Ltd.

www.torrentpharma.com

Latest From Torrent Pharmaceuticals Ltd.

Curatio Nets $20m Investment As Dermatology Stays On PE Menu

Private equity group ChrysCapital is investing $20m in the Indian firm Curatio Healthcare, underscoring the continuing interest in the niche dermatology space that generally sees healthy margins.

Commercial Strategy

Deal Watch: Sanofi Finds Ideal 'Partner' For Leukine

Partner Therapeutics takes on Sanofi's immunostimulant. Novartis transitions struggling Arzerra for compassionate use only outside the US, with compensation to Genmab, while Shire licenses I.V. immunoglobulin candidate from AB Biosciences.

Deals M & A

New Year Debut Of Another Biosimilar Humira In India

AbbVie may have managed to push back direct biosimilar competition to Humira (adalimumab) in the US by a few years, but 2018 has begun with the launch of yet another biosimilar of the blockbuster biologic in India. Hetero, the latest entrant, expects to maintain pricing parity with its peers on the domestic market.

Commercial Companies

Scrip 100 Analysis: Sales Up, Profits Down – But Is It Real?

Bellwethers tell you something, but to gauge the health of the pharmaceutical industry, you really need the Scrip 100. For FY 2016, it looks like drug sales are up again and profits are down. But is this what's actually going on?

Scrip 100 Sales & Earnings
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Torrent Pharmaceuticals Ltd.
  • Senior Management
  • Sudhir Mehta, Chmn.
  • Contact Info
  • Torrent Pharmaceuticals Ltd.
    Phone: (91) 79 2658 5090
    Torrent House, Off. Ashram Rd.
    Ahmedabad, 380 009
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register